1. Home
  2. COCP vs GENK Comparison

COCP vs GENK Comparison

Compare COCP & GENK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • GENK
  • Stock Information
  • Founded
  • COCP 2006
  • GENK 2011
  • Country
  • COCP United States
  • GENK United States
  • Employees
  • COCP N/A
  • GENK N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • GENK Restaurants
  • Sector
  • COCP Health Care
  • GENK Consumer Discretionary
  • Exchange
  • COCP Nasdaq
  • GENK Nasdaq
  • Market Cap
  • COCP 15.4M
  • GENK 16.3M
  • IPO Year
  • COCP N/A
  • GENK 2023
  • Fundamental
  • Price
  • COCP $1.07
  • GENK $2.70
  • Analyst Decision
  • COCP Strong Buy
  • GENK Strong Buy
  • Analyst Count
  • COCP 1
  • GENK 2
  • Target Price
  • COCP $6.00
  • GENK $7.00
  • AVG Volume (30 Days)
  • COCP 197.1K
  • GENK 67.4K
  • Earning Date
  • COCP 11-14-2025
  • GENK 11-07-2025
  • Dividend Yield
  • COCP N/A
  • GENK 4.36%
  • EPS Growth
  • COCP N/A
  • GENK N/A
  • EPS
  • COCP N/A
  • GENK N/A
  • Revenue
  • COCP N/A
  • GENK $216,137,000.00
  • Revenue This Year
  • COCP N/A
  • GENK $12.35
  • Revenue Next Year
  • COCP N/A
  • GENK $14.62
  • P/E Ratio
  • COCP N/A
  • GENK N/A
  • Revenue Growth
  • COCP N/A
  • GENK 10.67
  • 52 Week Low
  • COCP $1.00
  • GENK $2.62
  • 52 Week High
  • COCP $3.26
  • GENK $10.33
  • Technical
  • Relative Strength Index (RSI)
  • COCP 43.45
  • GENK 36.00
  • Support Level
  • COCP $1.06
  • GENK $2.75
  • Resistance Level
  • COCP $1.15
  • GENK $3.02
  • Average True Range (ATR)
  • COCP 0.07
  • GENK 0.17
  • MACD
  • COCP 0.01
  • GENK -0.03
  • Stochastic Oscillator
  • COCP 23.54
  • GENK 12.70

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first and in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About GENK GEN Restaurant Group Inc.

GEN Restaurant Group Inc operates an Asian casual dining restaurant chain, offering an extensive menu of traditional Korean and Korean-American food, including high-quality meats, poultry, seafood, and mixed vegetables. It operates 43 Gen Korean BBQ restaurants in the United States.

Share on Social Networks: